Official Title
CoronaCope - Internet-based Cognitive Behavioural Therapy for Adults Suffering From Mental Health Problems Related to the Coronavirus Pandemic
Brief Summary

The study seeks to investigate the effects of a guided internet-based cognitive behavioral therapy (ICBT) programme a on adult mental health problems related to the current coronavirus pandemic. ICBT will be compared to a wait-list control group. Participants will be recruited in Sweden with a nationwide recruitment.

Detailed Description

The study is set up as a randomized controlled trial. Quality of life, depressive symptoms,
anxiety, sleep problems and traumatic stress will be measured. Given uncertainties regarding
the psychological effects of Covid-19 pandemic a transproblematic tailored treatment approach
will be used that has been tested in several previous trials. However, the present program
has been adapted for the target population of people who are affected by the societal and
individual consequences of the pandemic. The study does not focus on people who have or have
had the corona virus.

Completed
Depression and Quality of Life Related to the Coronavirus Pandemic

Behavioral: Intervention group CoronaCope

Intervention based on cognitive behavioural therapy principles and adapted to the coronavirus pandemic situation. Intervention's main purpose is to mental health issues such as depressive symtoms, stress, worry and anxiety related to the coronavirus pandemic and increase quality of life in the current situation. Intervention contains psycho-educational elements as well as examples and exercises.

Eligibility Criteria

Inclusion Criteria:

- Experience mental health problems that are caused or exacerbated by the corona
pandemic and/or its consequences

- 18 years or older.

- Adequate ability to understand and speak Swedish.

- Access to the internet and a smartphone/computer.

Exclusion Criteria:

- Other ongoing psychological treatment or counselling that interfere with trial
treatment.

- Recent (within the past 3 months) changes in the dose of psychotropic medication.

- Any severe psychiatric or somatic conditions that would interfere with trial treatment

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
Sweden
Locations

Linköping University
Linköping, Östergötland, Sweden

Gerhard Andersson, PhD, Principal Investigator
Linkoeping University

Linkoeping University
NCT Number
Keywords
Corona
Covid-19
Internet-delivered cognitive-behavioral therapy (ICBT)
depression
Quality of Life
MeSH Terms
Coronavirus Infections
Depression